Can-Fite BioPharma Ltd.

Healthcare · Biotechnology · Israel

Last price 1.69 USD (Oct 30, 2026, 8:32 AM EDT) · Market cap 5.22M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treat...